The dynamic interaction of pediatric ALL cells and MSCs: influencing leukemic cell survival and modulating MSC β-catenin expression
Open Access
- 21 January 2025
- journal article
- research article
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 163 (1) , 1-10
Abstract
Bone marrow mesenchymal stromal cells (BM-MSCs) are integral components of the bone marrow microenvironment, playing a crucial role in supporting hematopoiesis. Recent studies have investigated the potential involvement of BM-MSCs in the pathophysiology of acute lymphoblastic leukemia (ALL). However, the exact contribution of BM-MSCs to leukemia progression remains unclear because of conflicting findings and limited characterization. In this study, we compared BM-MSCs derived from pediatric ALL patients with those from matched healthy donors (HDs). Our results indicate that while both ALL-MSCs and HD-MSCs meet the criteria established by the International Society for Cellular Therapy, they exhibit significant differences in proliferation and differentiation capacity. ALL-MSCs displayed markedly lower proliferation rates and reduced osteogenic/adipogenic differentiation potential compared to HD-MSCs. Furthermore, co-culture experiments revealed that MSCs enhance the survival of leukemic blasts through both soluble factors and direct cell-cell interactions, underscoring their anti-apoptotic properties. Importantly, our findings demonstrate that interactions with leukemic cells activate the Wnt/β-catenin signaling pathway in MSCs, suggesting a potential target for therapeutic intervention. Overall, this study enhances our understanding of the role of BM-MSCs in leukemia and highlights β-catenin as a promising target for future therapies.Keywords
Funding Information
- Ankara Yıldırım Beyazıt Üniversitesi (1644)
- ANKARA YILDIRIM BEYAZIT UNIVERSITY
This publication has 39 references indexed in Scilit:
- The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic VulnerabilitiesCurrent Hematologic Malignancy Reports, 2023
- The multiple ways Wnt signaling contributes to acute leukemia pathogenesisJournal of Leukocyte Biology, 2020
- Secreted Wnt antagonists in leukemia: A road yet to be pavedLeukemia Research, 2018
- The Effect of Granulocyte Colony–Stimulating Factor on Immune-Modulatory Cytokines in the Bone Marrow Microenvironment and Mesenchymal Stem Cells of Healthy DonorsTransplantation and Cellular Therapy, 2015
- Regulation of mesenchymal stromal cells through fine tuning of canonical Wnt signalingStem Cell Research, 2015
- Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemiaBlood Cancer Journal, 2014
- Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?Clinical and Experimental Medicine, 2013
- Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic targetCancer Letters, 2013
- Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapyLeukemia Research, 2012
- Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)Experimental Hematology, 2001